Driminate description, usages, side effects, indications, overdosage, supplying and lots more!

Driminate

Major Pharmaceuticals

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
Major 44-198



FULL PRESCRIBING INFORMATION

Dimenhydrinate 50 mg

Antiemetic

for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

for children under 2 years of age unless directed by a doctor.

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • difficulty in urination due to an enlargement of the prostate gland 

taking sedatives or tranquilizers.


  • marked drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • use caution when driving a motor vehicle or operating machinery

ask a health professional before use. 

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

  • to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
  • adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor
  • children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor
  • children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor

  • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • protect from moisture
  • see end flap for expiration date and lot number

croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silica gel, stearic acid 

(800) 616-2471

MAJOR®

NDC 0904-2051-59
*Compare to the Active Ingredient in DRAMAMINE® Tablets

Driminate™

Dimenhydrinate USP, Antiemetic

For Nausea, Dizziness and Vomiting from Motion Sickness

100 Tablets
50 mg EACH
Use as Directed

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

*This product is not manufactured or distributed by Prestige Brands, Inc., owner of the registered trademark Dramamine® Tablets.
50844    REV1013K19812

Distributed by MAJOR® PHARMACEUTICALS
31778 Enterprise Drive
Livonia, MI 48150 USA    M-17
Re-order No.  700621


Major 44-198-12

Driminate

Dimenhydrinate TABLET

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0904-2051
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DIMENHYDRINATE DIPHENHYDRAMINE 50 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
MAGNESIUM STEARATE
cellulose, microcrystalline
STEARIC ACID

Product Characteristics

Color Size Imprint Code Shape
WHITE 11 mm 44;198 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 BLISTER PACK
2 100 in 1 BOTTLE
3 NDC:0904-2051-59 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part336 1992-12-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.